AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Glimilen-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Aylen Pharmaceutical Pvt. Ltd.

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimilen-M1 Tablet SR

DiaGlycin-Duo SR tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. DiaGlycin-Duo SR should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as premature discontinuation without medical supervision can elevate glucose levels, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management, as directed by your doctor. Lifestyle modifications are vital for effective diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms such as sweating, lightheadedness, headache, and tremors. Prompt glucose intake (e.g., sugary snacks, fruit juice) is essential for management. Alcohol consumption should be limited due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Primary Ingredients of Glimilen-M1 Tablet SR

No text provided. Please provide the text you wish me to rephrase.

Uses of Glimilen-M1 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glimilen-M1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimilen-M1 Tablet SR with a meal.

Common Side effects of Glimilen-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimilen-M1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimilen-M1 Tablet SR should be administered with a meal.

How Glimilen-M1 Tablet SR works:

Glimepiride and Metformin, the components of Glimilen-M1 SR tablets, synergistically manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness throughout the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimilen-M1 Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimilen-M1 SR tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards before prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Glimilen-M1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity associated with this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glimilen-M1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Routine kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimilen-M1 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Glimilen-M1 Tablet SR is typically initiated at a low dosage; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimilen-M1 Tablet SR :

Should you forget a dose of Glimilen-M1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimilen-M1 Tablet SR

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glimilen-M1 Tablet SR

Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Glimilen-M1 Tablet SR use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially dangerous side effect of metformin is particularly risky for individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms may manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or a slow pulse. Should these symptoms appear, discontinue Glimilen-M1 Tablet SR and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimilen-M1 Tablet SR, manage type 2 diabetes mellitus (DM) in adults. This dual-action medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin concurrently decreases hepatic glucose production and improves the body's response to insulin. This formulation is unsuitable for treating type 1 DM.
Glimilen-M1 SR tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headaches. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Prolonged Glimilen-M1 Tablet SR use can indeed lead to Vitamin B12 deficiency by disrupting its gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as peripheral neuropathy (manifested as tingling, numbness in extremities, and weakness), urinary dysfunction, cognitive impairment, and ataxia. Preventive strategies, according to some studies, include supplemental Vitamin B12 intake at least annually.
Glimilen-M1 SR tablets can induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar include nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimilen-M1 Tablet SR and alcohol is unsafe. Concurrent use can depress blood glucose, potentially causing hypoglycemia, and heighten the risk of lactic acidosis.
Glimilen-M1 Tablet SR
44
MRP 54
18% off